The proprietary Microcyn^® Technology Platform is capable of producing a pH-neutral, non-irritating solution of oxychlorine compounds that are similar to the chemicals produced by the human body (neutrophils) in its defense against microorganisms. The mechanism of action of oxychlorine compounds against single-cell organisms, due to their reactivity with lipids and proteins in cell membranes, can cause these organisms to rupture and die.  It has been reported that Microcyn induces vasodialation and has demonstrated biocompatibility with fibroblast and granulation tissue.

The Microcyn Technology is capable of producing a highly controlled blend of oxychlorine chemicals specially formulated to demonstrate activity against a wide range of microorganisms at exceedingly low concentrations.  It is also this controlled balance of chemicals that is responsible for the technology’s extended stability, tissue biocompatibility, efficacy and safety.